Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736332 · ClinicalTrials.gov registry record · Phase 1
Factors Affecting Methamphetamine and Opiates Drug Testing
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
NCT01736332 is a Phase 1 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 29 participants.
The verdict
NCT01736332, a Phase 1 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
Background: \- Some legal over-the-counter drugs (such as Vicks VapoInhaler ) and some foods (such as poppy seeds) may cause a positive screening drug test. This might look like someone used illegal drugs (such as methamphetamines or opiates) when they did not. Researchers are studying how the body handles chemicals that may test like illegal drugs and for how long they may be detected in the body. Blood, saliva, and urine samples will be collected. This study may help improve the effectiveness and accuracy of drug tests. Objectives: \- To see how the body handles chemicals that may produce positive screening tests and how additional testing can eliminate positive drug tests from over-the-counter drugs and food. Eligibility: \- Healthy volunteers between 18 and 65 years of age. Design: * Participants are screened with a physical exam, medical history, laboratory tests, and ECG. * This study involves an overnight stay on a secure research unit and 2 days of tests. * On the first day, participants will take Vicks VapoInhaler (two inhalations in each nostril) every 2 hours from 9 a.m. to 7 p.m. They will also take a drink containing poppy seeds twice (at about 9 a.m. and 5 p.m.). * On the morning of the second day, participants will take the Vicks VapoInhaler just once. They will be discharged around 5 p.m. * On both days, participants will provide blood and saliva samples several times throughout the day. All of their urine will be collected during the 2 study days....
Interventions
- DRUG Vicks VapoInhaler
- OTHER Poppy seeds
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2012-07-19 |
| Est. Completion | 2014-01-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736332
The ClinicalTrials.gov registry entry for NCT01736332 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vicks VapoInhaler is the first listed.
NCT01736332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736332 about?
NCT01736332 is a clinical study titled "Factors Affecting Methamphetamine and Opiates Drug Testing". Background: \- Some legal over-the-counter drugs (such as Vicks VapoInhaler ) and some foods (such as poppy seeds) may cause a positive screening drug test. This might look like someone used illegal drugs (such as methamphetamines or opiates) when they did not. Researchers are studying how the body...
What is the current status of trial NCT01736332?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2012-07-19. Estimated completion is 2014-01-31.
What interventions are being tested in trial NCT01736332?
The interventions under investigation include: Vicks VapoInhaler (DRUG), Poppy seeds (OTHER).
Who is sponsoring clinical trial NCT01736332?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.